GLIS2 and acute myeloid leukemia: CBFA2T3 expression levels are elevated in lymphoid and myeloid based cell lines, and genetic CBFA2T3 fusion with RUNX1 or GLIS2 accelerates acute myeloid leukemia and megakaryoblastic leukemia [4].